Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease
Open accessThe DOI matches its Crossref record; 189 of the 192 references it cites were found in a registry or an index; 119 of the 211 sources its claims cite were checked for support.
Abstract
Oxidative and nitrosative stress are widely recognized as critical factors in the pathogenesis and progression of Alzheimer disease (AD) and its earlier stage, amnestic mild cognitive impairment (MCI). A major source of free radicals that lead to oxidative and nitrosative damage is mitochondria. This review paper discusses oxidative and nitrosative stress and markers thereof in the brain, along with redox proteomics, which are techniques that have been pioneered in the Butterfield laboratory. Selected biological alterations in-and oxidative and nitrosative modifications of-mitochondria in AD and MCI and systems of relevance thereof also are presented. The review article concludes with a section on the implications of mitochondrial oxidative and nitrosative stress in MCI and AD with respect to imaging studies in and targeted therapies toward these disorders. Taken together, this review provides support for the notion that brain mitochondrial alterations in AD and MCI are key components of oxidative and nitrosative stress observed in these two disorders, and as such, they provide potentially promising therapeutic targets to slow-and hopefully one day stop-the progression of AD, which is a devastating dementing disorder.
Overview
CoChat Summary
TL;DR
This is a review arguing that mitochondrial oxidative and nitrosative stress are central to Alzheimer disease (AD) and amnestic mild cognitive impairment (MCI), and that mitochondria may be promising therapeutic targets. It synthesizes evidence from brain, cell, animal, and peripheral-cell studies, including redox proteomics, imaging, and mitochondria-targeted interventions.
Key findings
- The review states that oxidative/nitrosative stress and mitochondrial dysfunction are widely recognized as critical in AD and MCI, and that mitochondria are a major source of the free radicals that cause this damage.
- Redox proteomics identified oxidized/nitrated mitochondrial proteins in AD and MCI brain, including aconitase, malate dehydrogenase, ATP synthase, lactate dehydrogenase-B, MnSOD, p53, VDAC1, EF-Tu, HSP70, and HSP90; the paper reports that activities of LDH, aconitase, and ATP synthase are significantly decreased, while MDH activity is significantly increased.
- In mitochondria isolated from lymphocytes of MCI and AD patients, protein-bound carbonyls, 3-NT, and HNE were significantly increased and correlated with elevated Aβ, decreased small-molecule antioxidants, and decreased cognitive test performance.
- The paper reports intervention-related findings including that Mdivi-1 protected against ROS production, loss of mitochondrial transport, synaptic damage, neuronal death, and stunted neuritic spines in untreated mice, while alpha-lipoic acid improved outcomes in dogs/rodents and a small clinical pilot study found slower cognitive decline; CoQ10 and MitoQ improved pathology or memory in transgenic mouse models.
Methods
- Narrative review of published studies on mitochondrial oxidative/nitrosative stress in AD and MCI, with emphasis on evidence from human brain, peripheral cells, in vitro systems, and animal models.
- Synthesizes studies using redox proteomics and related proteomic approaches to identify oxidatively/nitrosatively modified proteins and compare AD/MCI samples with controls.
- Integrates findings with imaging, metabolic, and therapeutic studies, including longitudinal and intervention reports mentioned in the text.
Limitations
- Not a primary empirical study; it is a review, so it does not present a single new sample, cohort, or original statistical analysis.
- The authors explicitly note that more research is needed in several places, including whether ketone supplementation is beneficial, whether apoE4-related astrocytic glucose-utilization differences occur in vivo, and how mitochondrial-targeted therapies should be developed.
- Evident from the text: many findings are drawn from heterogeneous prior studies across different models, tissues, and disease stages, so the review itself cannot establish causality or uniform effect sizes.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Redox proteomics identified oxidatively modified, mitochondrial proteins in brains from persons with Alzheimer disease or amnestic mild cognitive impairment. Proteins marked with a red star are oxidatively modified. Functional classes of oxidatively dysfunctional proteins include those related to: Glucose metabolism, i.e., lactate dehydrogenase (LDH), aconitase, malate dehydrogenase (MDH), ATP synthase; Export of anions (ATP, for example, has a decreased chance of export through voltage-dependent anion channel 1 (VDAC1) to drive neuronal function including the maintenance of mitochondrial potential); Free radical scavenging (MnSOD, which increases opportunities to cause further oxidative and nitrosative damage to mitochondria); mitochondrial protein synthesis (EF-Tu, which would lead to altered levels of key proteins needed to assemble into functional inner membrane resident electron transport complexes and thereby decrease ATP levels); and chaperone and transport function for the import of nuclear-encoded proteins into mitochondria (heat shock protein 70 (HSP70); heat shock protein 90 (HSP90), which also could contribute to altered protein levels of needed electron transport chain [(ETC) complexes and other key proteins]. See text for further details.](https://figures.cochat.ai/paper-figures/ac99b96fdd8e48f69d70649bcfc76e38/mitochondrial-oxidative-and-nitrosative-stress-and-alzheimer-disease-figure-3.jpg)

Verification
Claims the paper makes
73 Valid · 5 Not valid · 30 Not checked · 20 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“elegant research from Mahley’s laboratory demonstrated in Neuro-2a neuronal cells expressing stable isoforms of apolipoprotein E (apoE), i.e., apoE2, apoE3, or apoE4, with the latter a major risk factor for developing AD, that apoE4 is excessively produced by damaged neurons [31].”
§ Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease > 3. Selected Biological Alterations in AD Mitochondria
What the sources say
- Partly supportedcites [31] Huang, 2014, Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer’s diseases, Neurobiol. Dis. sourceExperimental — accuracy not yet measured
In “Synthesis of ApoE in Different Tissues and Cells” (page unavailable), the review reports that hippocampal and cortical neurons express apoE in response to injury. In “ApoE4 proteolysis and neurotoxicity” (page unavailable), it hypothesizes that injury enhances neuronal apoE expression, but does not establish that damaged neurons excessively produce apoE4 specifically. Its discussion of apoE-transfected Neuro-2a cells concerns neurite extension, not production by damaged neurons. (LLM, conf=0.88)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“With the NO2 functionality on Tyr, tyrosine phosphorylation by tyrosine kinases, including receptor tyrosine kinases, is inhibited due to steric interference of the NO2 group with the active site of the enzyme.”
§ Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease > 2. Mitochondria and Oxidative and Nitrosative Stress
What the sources say
- Could not verifycites [8] Butterfield, 2019, Oxidative stress, glucose dysmetabolism and Alzheimer disease, Nat. Rev. Neurosci. sourceExperimental — accuracy not yet measured
The 'Oxidative Damage is relevant to AD' section reports elevated 3-nitrotyrosine, and 'Proteostasis Abnormalities in AD' discusses receptor tyrosine kinases. Neither passage links tyrosine nitration to inhibited phosphorylation or attributes such inhibition to steric interference by an NO2 group. Searches for that mechanism and for nitration-related kinase inhibition found no supporting passage; page numbers were unavailable in our copy. (LLM, conf=0.76)
- Not checked — no full text of the sourcecites [13] Halliwell, B., and Gutteridge, J.M.C. (2015). Free Radicals in Biology & Medicine, Oxford University Press. [5th ed.]. source
- Not checked — no full text of the sourcecites [29] Radi, 2018, Oxygen radicals, nitric oxide, and peroxynitrite: Redox pathways in molecular medicine, Proc. Natl. Acad. Sci. USA source
- Partly supportedcites [30] Bartesaghi, 2017, Tyrosine-nitrated proteins: Proteomic and bioanalytical aspects, Antioxid. Redox Signal. sourceExperimental — accuracy not yet measured
The Introduction says that adding a bulky NO2 group to a relevant tyrosine residue can impose steric restrictions and inhibit tyrosine phosphorylation. It does not specifically say that the inhibition results from interference with a tyrosine kinase’s active site, or identify receptor tyrosine kinases in this account. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The former leads to the incorporation of carbonyl functionalities in proteins and alterations in protein conformation (and normally loss of function as a consequence) [8,22,23,24]”
§ Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease > 2. Mitochondria and Oxidative and Nitrosative Stress
What the sources say
- Partly supportedcites [8] Butterfield, 2019, Oxidative stress, glucose dysmetabolism and Alzheimer disease, Nat. Rev. Neurosci. sourceExperimental — accuracy not yet measured
The ‘Oxidative Damage is relevant to AD’ section identifies protein carbonyls as markers of oxidative damage, and ‘Contribution of oxidative damage’ says oxidative modification almost always decreases the activity of the glucose-metabolism enzymes it discusses. The concluding remarks link changed protein conformation and reduced activity to reactive aldehydes from lipid peroxidation. Our copy does not establish the claimed sequence specifically for hydroxyl-radical reactions with proteins. (LLM, conf=0.82)
- Not checked — no full text of the sourcecites [22] Butterfield, 1997, Protein oxidation processes in aging brain, Adv. Cell Aging Gerontol. source
- Not checked — no full text of the sourcecites [23] Tramutola, 2017, Oxidative stress, protein modification and Alzheimer disease, Brain Res. Bull. source
- Partly supportedcites [24] Ren, 2019, Profiles of brain oxidative damage, ventricular alterations, and neurochemical metabolites in the striatum of PINK1 Kkockout rats as functions of age and gender: Relevance to parkinson disease, Free Radic. Biol. Med. sourceExperimental — accuracy not yet measured
The Methods (Slot blot assay; page unavailable) measure protein carbonyls, and the Discussion (page unavailable) treats them as biomarkers of oxidative damage. The paper does not say that hydroxyl radicals incorporate carbonyl groups into proteins or that this changes protein conformation and normally causes loss of function. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In that case, H2O2, which has zero dipole moments and is therefore neutral and can diffuse into or through bilayers, can be decomposed to hydroxyl anion and the highly reactive hydroxyl free radical by Fe2+ or Cu+ in a process known as Fenton chemistry [8,13].”
§ Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease > 2. Mitochondria and Oxidative and Nitrosative Stress
What the sources say
- Partly supportedcites [8] Butterfield, 2019, Oxidative stress, glucose dysmetabolism and Alzheimer disease, Nat. Rev. Neurosci. sourceExperimental — accuracy not yet measured
The section “Oxidative Damage is relevant to AD” describes OH• as highly reactive and H2O2 as less reactive. Our copy does not state that Fe2+ or Cu+ decomposes H2O2 into hydroxyl anion and hydroxyl radical through Fenton chemistry; searches for Fenton chemistry and the metal-ion reaction found no such passage. Page numbers were not available in the indexed copy. (LLM, conf=0.78)
- Not checked — no full text of the sourcecites [13] Halliwell, B., and Gutteridge, J.M.C. (2015). Free Radicals in Biology & Medicine, Oxford University Press. [5th ed.]. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“As electron flow occurs in the multiple redox-sensitive proteins within Complex I on the inner membrane, electron leak occurs, usually in the form of superoxide radical anion or the hydrogendioxide radical, elevating oxidative stress (Figure 1) [8,16,17].”
§ Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease > 2. Mitochondria and Oxidative and Nitrosative Stress
What the sources say
- Could not verifycites [8] Butterfield, 2019, Oxidative stress, glucose dysmetabolism and Alzheimer disease, Nat. Rev. Neurosci. sourceExperimental — accuracy not yet measured
The “Oxidative Damage is relevant to AD” section lists superoxide among reactive oxygen species and defines oxidative stress, while “Contribution of oxidative damage” discusses oxidative damage in mitochondria (page numbers unavailable). Searches for Complex I, electron leakage, and superoxide production did not find a passage linking electron flow through Complex I to the claimed radicals or increased oxidative stress. (LLM, conf=0.72)
- Not checked — no full text of the sourcecites [16] Dhar, 2012, Manganese superoxide dismutase regulation and cancer, Free Radic. Biol. Med. source
- Not checked — no full text of the sourcecites [17] Nelson, 2006, The induction of human superoxide dismutase and catalase in vivo: A fundamentally new approach to antioxidant therapy, Free Radic. Biol. Med. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
58 more claims · 33 with their cited sources checked
Create a free account to see all 128 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 52
- Probably not a substantial claim. 19
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite incredible efforts, there is still a lack of effective drugs for the treatment of AD.”
From Multi-target neuroprotective effects of herbal medicines for Alzheimer's disease (2022) · cites this paper as Butterfield and Boyd-Kimball, 2020
Experimental — accuracy not yet measuredIn the citing paper
“There are five drugs in clinic, including three cholinesterase inhibitors, that only provide palliative and supporting treatment (Butterfield and Boyd-Kimball, 2020;Zagórska and Jaromin, 2020;Gul et al., 2021).”
From Multi-target neuroprotective effects of herbal medicines for Alzheimer's disease (2022) · cites this paper as Butterfield and Boyd-Kimball, 2020
In the citing paper
“ROS and reactive nitrogen species (RNS) are capable of damaging and modifying several types of macromolecules, such as DNA, RNA, lipids, and proteins, compromising the normal functions of the cells (Butterfield and Boyd-Kimball, 2020; Persson et al., 2014).”
From Multi-target neuroprotective effects of herbal medicines for Alzheimer's disease (2022) · cites this paper as Butterfield and Boyd-Kimball, 2020
In the citing paper
“However, ChE inhibitors are not able to completely stop the progression of AD, and research should focus on the development of multi-target drugs able to counteract the decreased levels of ACh, protein misfolding and associated Aβ aggregation, hyperphosphorylation of tau protein, and oxidative stress (Butterfield and Boyd-Kimball, 2020;Zagórska and Jaromin, 2020).”
From Multi-target neuroprotective effects of herbal medicines for Alzheimer's disease (2022) · cites this paper as Butterfield and Boyd-Kimball, 2020
Citations
Cites
Free Radicals in Biology and Medicine
Halliwell, B., & Gutteridge, J. M. C. (2015) · doi:10.1093/acprof:oso/9780198717478.001.0001 · Cited by 8,990
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Mitochondrial Fission, Fusion, and Stress
Youle, R. J., & van der Bliek, A. M. (2012) · Science · doi:10.1126/science.1219855 · Cited by 3,674 · cited 2×
“Among other functions, mitochondrial fission is involved in the regulation of mitophagy, apoptosis, and the cellular need for ATP [38].”
BackgroundSies, H., Berndt, C., & Jones, D. P. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045037 · Cited by 3,520 · cited 1×
“Other mitochondrial-related antioxidant systems include, among others, thioredoxin [18], peroxiredoxin 4 [19], glutathione peroxidase 4 [20], and methionine sulfoxide reductase A [21].”
BackgroundWallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185 · cited 2×
“Mitochondrial oxidative stress is increased by the consumption of excess calories and, in turn, it leads to mitochondrial DNA damage [120], which has been described in an AD brain [169,170] in which base deletions correlate with complex IV deficiency in an AD hippocampus [171].”
Background2020 Alzheimer's disease facts and figures
(2020) · Alzheimer's & Dementia · doi:10.1002/alz.12068 · Cited by 2,353
Villemagne, V. L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K. A., Salvado, O., Szoeke, C., Macaulay, S. L., Martins, R., Maruff, P., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70044-9 · Cited by 2,279
Cellular energy utilization and molecular origin of standard metabolic rate in mammals
Rolfe, D. F., & Brown, G. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.3.731 · Cited by 2,021 · cited 1×
“The human brain comprises approximately 2% of body mass but consumes approximately 20% of daily oxygen intake [118].”
Background
Cited by
Perluigi, M., Di Domenico, F., & Butterfield, D. A. (2024) · Physiological Reviews · doi:10.1152/physrev.00030.2022 · Cited by 282
Self-citationChiaradia, E., Tancini, B., Emiliani, C., Delo, F., Pellegrino, R. M., Tognoloni, A., Urbanelli, L., & Buratta, S. (2021) · Cells · doi:10.3390/cells10071763 · Cited by 241
Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria
Gowda, P., Reddy, P. H., & Kumar, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101529 · Cited by 163
Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress
Rummel, N. G., & Butterfield, D. A. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0177 · Cited by 118
“There is widespread agreement across many laboratories that oxidative stress is a key contributor to the pathogenesis and progression of AD (15, 17, 20–22, 90, 102, 114, 135).”
Self-citationÜremiş, N., & Üremiş, M. M. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70133 · Cited by 114
AlCl3 induced learning and memory deficit in zebrafish
Kaur, K., Narang, R. K., & Singh, S. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.07.004 · Cited by 79
Li, Y., Li, X., Wei, L.-S., & Ye, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1451989 · Cited by 102
Lanzillotta, C., Tramutola, A., Di Giacomo, G., Marini, F., Butterfield, D. A., Di Domenico, F., Perluigi, M., & Barone, E. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.042 · Cited by 47
Self-citationMulti-target neuroprotective effects of herbal medicines for Alzheimer's disease
Fernandes, F., Barroso, M. F., De Simone, A., Emriková, E., Dias-Teixeira, M., Pereira, J. P., Chlebek, J., Fernandes, V. C., Rodrigues, F., Andrisano, V., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115107 · Cited by 45
Fu, Y., & Jia, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.638772 · Cited by 47
Neuroprotective Roles of the Reverse Transsulfuration Pathway in Alzheimer’s Disease
Paul, B. D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.659402 · Cited by 42
“The mutations that elevate homocysteine include 677C > T, 1298A > C (Castro et al., 2003).”
BackgroundBashir, S., Uzair, M., Abualait, T., Arshad, M. M. U. D., Khallaf, R. A., Niaz, A., Thani, Z., Yoo, W., Túnez, I., Demirtaş-Tatlıdede, A., et al. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12625 · Cited by 47
Wang, J., Cao, Y., Yang, L., Zhu, H., Zhang, J., Che, J., Zhuang, R., & Shao, J. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115998 · Cited by 42
NOX-induced oxidative stress is a primary trigger of major neurodegenerative disorders
Zilberter, Y., Tabuena, D. R., & Zilberter, M. Y. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102539 · Cited by 37
“Mitochondria in the AD brain are susceptible to accumulating oxidative damage (Butterfield and Boyd-Kimball, 2020; Dewanjee et al., 2022; Mecocci et al., 1997, 1994).”
BackgroundJové, M., Mota‐Martorell, N., Torres, P., Ayala, V., Portero‐Otín, M., Ferrer, I., & Pamplona, R. (2021) · Life · doi:10.3390/life11050388 · Cited by 33
“Thus, there is a significant number of selectively modified proteins described in different cortical regions of the brain at different stages of AD [18,141,144,146,149,152].”
BackgroundButterfield, D. A., Favia, M., Spera, I., Campanella, A., Lanza, M., & Castegna, A. (2022) · Molecules · doi:10.3390/molecules27030951 · Cited by 31
Self-citationGrotto, F. S., & Glaser, V. (2023) · BioMetals · doi:10.1007/s10534-023-00530-9 · Cited by 31
“…changes in antioxidant system, lipid peroxidation, and oxidation/nitrotyrosination of proteins or DNA, resulting in oxidative stress that compromises cell survival (Butterfield and Boyd-Kimball 2020; Hemmati-Dinarvand et al. 2019; Isibor et al. 2022; Kaur et al. 2021; Singh et al. 2013).”
Oxidative Stress in Brain in Amnestic Mild Cognitive Impairment
Butterfield, D. A. (2023) · Antioxidants · doi:10.3390/antiox12020462 · Cited by 32
“It is well known that mitochondrial functions are deficient in AD [130,131] and MCI [86,132], and our studies showing specific mitochondrial proteins are oxidatively modified contribute to the understanding of why brain mitochondrial functions are diminished in these disorders compared to age-matched control brains.”
BackgroundSelf-citationThe Potential Roles of Redox Enzymes in Alzheimer’s Disease: Focus on Thioredoxin
Jia, J., Zeng, X., Xu, G., & Wang, Z. (2021) · ASN NEURO · doi:10.1177/1759091421994351 · Cited by 29
“Oxidative stress is in turn associated with amyloid-peptide oligomer inserted in the mitochondrial membranes, which will lead to more serious oxidative stress (Butterfield and Boyd-Kimball, 2020).”
BackgroundHerbet, M., Szumełda, I., Piątkowska‐Chmiel, I., Gawrońska‐Grzywacz, M., & Dudka, J. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113185 · Cited by 25
Luo, Y., Li, Z., Wang, X., Wang, J., Duan, X., Li, R., Peng, Y., Ye, Q., & He, Y. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1016833 · Cited by 25
Sood, P., Singh, V., & Shri, R. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01199-2 · Cited by 26
“Growing evidences from experimental studies suggest that the oxidative and nitrosative stress are the crucial factors that lead to AD progression (Kaur et al. 2017; Singh et al. 2016; Butterfield and Boyd-Kimball 2020; Pruthi et al. 2021; Bhatia et al. 2022).”
BackgroundAdesina, A. F., Adewuyi, A., & Otuechere, C. A. (2024) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2024.100413 · Cited by 24
Yang, Z., Yu, R., Cao, Z., Wu, Y., Zhao, X., Xie, Q., Luo, M., & Liu, Y. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.625843 · Cited by 25
“Mitochondrial dysfunction, in turn, accelerates the production of reactive oxygen species, further contributing to oxidative stress and damage to cell membrane lipids, intracellular proteins, and DNA (Butterfield and Boyd-Kimball, 2020).”
BackgroundMitochondrial dysfunction: A potential target for Alzheimer’s disease intervention and treatment
Ke, J., Tian, Q., Xu, Q., Fu, Z., & Fu, Q. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.04.025 · Cited by 23
Uniyal, A., Akhilesh, A., Tiwari, V., Gadepalli, A., Ummadisetty, O., & Tiwari, V. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00794-5 · Cited by 21
Evaluating the effect of selenium on spatial memory impairment induced by sleep deprivation
Massadeh, A. M., Alzoubi, K. H., Milhem, A. M., Rababa’h, A. M., & Khabour, O. F. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113669 · Cited by 25
Role of Mitochondria in Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease
Chernyavskij, D. A., Galkin, I. I., Pavlyuchenkova, A. N., Fedorov, A. V., & Chelombitko, M. A. (2023) · Molecular Biology · doi:10.1134/s0026893323060043 · Cited by 29
“It should be noted that oxidative and nitrosative stresses underlie many disorders that are associated with inflammation [63, 84–86].”
BackgroundDong, Y., Li, T., Wang, S.-S., Hu, Y.-H., Liu, Y., Zhang, F., Sun, T.-S., Zhang, C.-J., Du, Q., & Li, W. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118237 · Cited by 20
Treviño, S., Pulido, G., Fuentes‐Medel, E., Handal‐Silva, A., Moreno-Rodriguez, A., Venegas, B., Flores, G., Guevara, J., & Díaz, A. (2022) · Synapse · doi:10.1002/syn.22242 · Cited by 20
Zhu, Y., Kohli, N., Young, A. J., Sheldon, M., Coni, J., Rajasekaran, M., Robinson, L., Chroneos, R., Riley, S., Guarnieri, J. W., et al. (2024) · Antioxidants · doi:10.3390/antiox13101226 · Cited by 20
Ciccone, L., Nencetti, S., Rossello, A., & Orlandini, E. (2023) · Pharmaceuticals · doi:10.3390/ph16071036 · Cited by 21
“Reactive oxygen species (ROS) can provoke nucleic acid breakage, polysaccharide depolymerization, lipid peroxidation, and other dramatic effects that cause damage to neurons and cell death [26,27].”
BackgroundEffect of N-Acetyl Cysteine as an Adjuvant Treatment in Alzheimer’s Disease
Martínez, S. M. L., Pacheco-Moisés, F. P., Bitzer-Quintero, O. K., Ramírez-Jirano, L. J., Delgado-Lara, D. L. C., Cortés-Trujillo, I., Jasso, J. H. T., Flores, J. S., & Torres-Sánchez, E. D. (2025) · Brain Sciences · doi:10.3390/brainsci15020164 · Cited by 23
Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer’s Disease
Tassone, G., Kola, A., Valensin, D., & Pozzi, C. (2021) · Life · doi:10.3390/life11050386 · Cited by 22
“Redox proteomics has been widely applied to determine oxidatively modified proteins in mitochondria of both in vitro and in vivo AD models and of AD brains [76–78,80,81], supporting the hypothesis that both oxidative stress and mitochondrial dysfunction are early events in the insurgence and progression of AD [10,79,9…”
BackgroundNuzzo, D., Frinchi, M., Giardina, C., Scordino, M., Zuccarini, M., Simone, C. D., Carlo, M. D., Belluardo, N., Mudò, G., & Liberto, V. D. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01274-9 · Cited by 17
“2011; Butterfield and Boyd-Kimball 2020).”
BackgroundDCE-MRI of Brain Fluid Barriers: In Vivo Water Cycling at the Human Choroid Plexus
Anderson, V. C., Tagge, I., Doud, A., Li, X., SPRINGER, C. S. J., Quinn, J. F., Kaye, J. A., Wild, K. V., & Rooney, W. D. (2021) · Tissue Barriers · doi:10.1080/21688370.2021.1963143 · Cited by 17
“Mitochondrial defects and accumulated oxidative damage impair function and hinder processes that reduce deleterious effects on ATP production.(15) Moreover, gene expression studies suggest that mitochondrial damage plays a major role in cognitive decline.”
BackgroundMitochondrial and Neuronal Dysfunctions in L1 Mutant Mice
Congiu, L., Granato, V., Loers, G., KLEENE, R. B., & Schachner, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084337 · Cited by 13
Vafaei, A., Vafaeian, A., Iranmehr, A., Nassireslami, E., Hasannezhad, B., & Hosseini, Y. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14892 · Cited by 13
“12 The interconnectedness of these concepts lies in the fact that oxidative/nitrosative stress contributes to mitochondrial dysfunction.”
BackgroundWang, R., Wu, G., Mu, Y., et al. (2022) · Dyes and Pigments · doi:10.1016/j.dyepig.2022.110487 · Cited by 12
Ali, A., Babar, Q., Saeed, A., Sergi, D., Naumovski, N., Ahmed, I. A. M., Shamlan, G. H., Hafiz, H., Manzoor, M. F., Trafiałek, J., et al. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70385 · Cited by 16
Mitochondrial Oxidative and Nitrosative Stress as a Therapeutic Target in Diseases
Marí, M., & Colell, A. (2021) · Antioxidants · doi:10.3390/antiox10020314 · Cited by 12
“These studies are extensively reviewed in the article by Butterfield and Boyd–Kimball [3].”
MethodNaderian, R., Nazari, M. A., Meybodi, T. E., Paraandavaji, E., Lagzian, A., Nikandish, M., & Eslami, M. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-025-01775-8 · Cited by 12
“Such mechanisms underscore how redox imbalances not only damage cells but also lead to clinically significant neurobehav - ioral impairments (Butterfield and Boyd-Kimball 2020).”
Role of Thioredoxin System in Regulating Cellular Redox Status in Alzheimer’s Disease
Qaiser, H., Uzair, M., Al-Regaiey, K., Rafiq, S., Arshad, M., Yoo, W., Arain, O. Z., Kaleem, I., Abualait, T., Wang, L., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230394 · Cited by 12
“It has been shown that OS and free radical damage correlated with histopathological hallmarks of AD, i.e., A (cid:2) and NFTs [10, 11].”
Piccirillo, S., Preziuso, A., Serfilippi, T., Cerqueni, G., Terenzi, V., Lariccia, V., & Magi, S. (2025) · Current Neuropharmacology · doi:10.2174/011570159x345397241210103538 · Cited by 15
“Since different antioxidants have demonstrated protective effects against the neurodegenerative spiral induced by Alzheimer's redox imbalance [25, 84], methanol extracts of G. tiliaefolia may be protective as well.”
Faryadras, K., Golchoobian, R., Iranzadeh, S., & Roghani, M. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1567236 · Cited by 13
Behof, W. J., Whitmore, C. A., Haynes, J. R., Rosenberg, A. J., Tantawy, M. N., Peterson, T. E., Harrison, F. E., Beelman, R. B., Wijesinghe, P., Matsubara, J. A., et al. (2022) · FEBS Letters · doi:10.1002/1873-3468.14303 · Cited by 11
Tarbali, S., Zahmatkesh, M., Torkaman‐Boutorabi, A., & Khodagholi, F. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111645 · Cited by 8
Grifola frondosa polysaccharides alleviate Alzheimer's disease in rats
Behrad, S., Pourranjbar, S., Pourranjbar, M., Abbasi-Maleki, S., Mehr, S. R., Salmani, R. H. G., & Moradikor, N. (2024) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/apjtb.apjtb_294_24 · Cited by 7
A Novel NOX Inhibitor Alleviates Parkinson’s Disease Pathology in PFF-Injected Mice
Ofori, K., Ghosh, A., Verma, D., Wheeler, D., Cabrera, G. N., Seo, J. B., & Kim, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814278 · Cited by 7
Chernyavskij, D. A., Galkin, I. I., Pavlyuchenkova, A. N., Fedorov, A. V., & Chelombitko, M. A. (2023) · Molecular Biology · doi:10.31857/s0026898423060058 · Cited by 21
Tortolani, D., Decandia, D., Giacovazzo, G., Scipioni, L., Panuccio, A., Ciaramellano, F., Eugelio, F., Fanti, F., Latagliata, E. C., Barbera, L. L., et al. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1571428 · Cited by 7
Targeting NOX inhibitors in neurodegeneration: a therapeutic perspective
Kaur, S., Verma, R., Sharma, V., & Singh, T. G. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01644-4 · Cited by 7
“The brain is vulnerable to accumulated oxidative damage due to the production of ROS at several locations inside mitochondria (Butterfield and Boyd-Kimball 2020; Dewanjee et al. 2022).”
Karimi‐Zandi, L., Ghorbandaiepour, T., & Zahmatkesh, M. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137446 · Cited by 6
Elucidation of phytochemicals and antioxidants properties ofSasa quelpaertensis
Ko, H., Jang, M. G., Kim, J.-W., Baek, S., Lee, N. H., & Kim, S. (2021) · International Journal of Food Properties · doi:10.1080/10942912.2021.1873362 · Cited by 5
“Oxidative and nitrosative stress is associated with various diseases such as cancer, inflammation, Alzheimer’s, atherosclerosis, and arteriosclerosis.([5,6]) Therefore, research to isolate antioxidant compounds from natural resources”
BackgroundMesa-Herrera, F., Marín, R., Torrealba, E., & Díaz, M. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215437 · Cited by 5
Asgarshamsi, M. H., Fassihi, A., & Dehkordi, M. M. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202300325 · Cited by 4
Nguyen, H. V. M., Ran, Q., Salmon, A. B., Ahn, B., Chiao, Y. A., Bhaskaran, S., & Richardson, A. G. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.10.269 · Cited by 5
da Silva, J. F., Polk, F. D., Martin, P. E., Thai, S. H., Savu, A., Gonzales, M., Kath, A., Gee, M. T., & Pires, P. W. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14438 · Cited by 11
Nitric oxide synthase activity: A novel potential biomarker for predicting Alopecia areata
Taşkın, S., Çelık, H., Çakırca, G., Manav, V., & Taşkın, A. (2022) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.15378 · Cited by 4
Ahmad, F., Ramamoorthy, S., Areeshi, M. Y., Ashraf, G. M., & Haque, S. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230303123555 · Cited by 4
Wei, S., Li, Y., Yu, X., Ding, R., & Meng, G. (2025) · Brain Circulation · doi:10.4103/bc.bc_180_24 · Cited by 4
“[73] Reactive oxygen spices (ROS) and peroxynitrite (generated by diffusion-controlled responses between superoxide radicals and NO), as typical hallmarks of oxidative and nitrative stress, respectively, increased uncontrollably in the early post-CVT period.”
Kashif, O., & Said, M. (2025) · Discover Medicine · doi:10.1007/s44337-025-00455-x · Cited by 4
“This modification can adversely affect cell survival by interfering with signaling pathways dependent on tyrosine phosphorylation [27].”
Functional Relationships between L1CAM, LC3, ATG12, and Aβ
Loers, G., Bork, U., & Schachner, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910829 · Cited by 3
“During early stages of AD, protein and lipid oxidation in brain regions rich in A β were found [72].”
BackgroundZhu, Y., McManus, M. J., & Mach, R. H. (2025) · Academic Radiology · doi:10.1016/j.acra.2025.07.061 · Cited by 2
“…a “silent” onset, beginning decades before clinical symptoms emerge (1,2), with early pathological changes including glucose hypometabolism (3,4), inflammation (5), and oxidative stress, primarily driven by mitochondrial dysfunction and excessive reactive oxygen species (ROS) production (6–10).”
Biswas, S., Sengupta, A., Das, S., Dey, C., Sengupta, R., Ghosh, A., & Ghosh, S. (2025) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2025.130845 · Cited by 4
Chakraborty, S., Mishra, A., Choudhuri, A., Bhaumik, T., & Sengupta, R. (2024) · Nitric Oxide · doi:10.1016/j.niox.2024.05.002 · Cited by 1
Neurodegenerative Diseases and Succinate Dehydrogenase: A Therapeutics Avenue for Treatment
Viswalingam, V., & Kumar, D. (2025) · Springer eBooks · doi:10.1007/978-981-96-6831-1_9 · Cited by 1
Filiberti, V., Andreu, A. B., & Silveyra, M. X. (2025) · Waste and Biomass Valorization · doi:10.1007/s12649-025-03390-1 · Cited by 1
Belenichev, I. F., Aliyeva, O. G., Bukhtiyarova, N. V., Ryzhenko, V. P., Бурлака, Б. С., Burlaka, K., Skoryna, D., Petakh, P., & Kamyshnyi, O. (2025) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2025.1670565 · Cited by 4
Motamed, Z., Novack, G. V., Heutschi, D., Gaiser, C., Garcia, C., Carmo, S. D., Cuello, A. C., Morelli, L., & Suter‐Dick, L. (2026) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2026.01.006 · Cited by 1
Cai, Y., Dai, W., Liu, F., Li, Z., & Liu, G. (2026) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s589176 · Cited by 1
“The F-values ranged from 150.87 to 68,733.53, demonstrating strong instrument strength (Supplementary Tables 1–4).”
InfluentialAnar, M. A., Fathollahi, M. A., Zare, F., Farrokhi, Z., Habibzadeh, E., Hasany, S., Mirmazloumi, M., Bafrani, M. A., Kenari, F. A., Falahati, M., et al. (2026) · Metabolic Brain Disease · doi:10.1007/s11011-026-01895-9 · Cited by 1
“Over the past three decades, numerous human studies have investigated mitochondrial enzymes in Alzheimer’s disease, examining activity, abundance, and susceptibility to oxidative or nitrosative modification (Alkhalifa et al. 2025 ; Butterfield and Boyd-Kimball 2020; Nakamura et al. 2021).”
da Silva, J. F., Polk, F. D., Martin, P. E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.06.543962 · Cited by 1
“Peroxynitrite can be generated in cells after a reaction between nitric oxide (NO) and superoxide (O2) in a pro-oxidative environment (29-31).”
BackgroundKe, J., Zhao, P., Li, J., & Fu, Q. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4126940
Jan, A., Shah, M., Shah, S. A., Syed, H. H., & Ehtesham, E. (2023) · Research Square · doi:10.21203/rs.3.rs-3376865/v1
Role of Enzymes in Prion Disease: A Molecular Mechanism
Firdous, S. M., Pal, S., & Mandal, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-6822-6_8
Justo, A. F. O., Toscano, E. C. D. B., Gonçalves, N. G., Leite, R. E. P., Paes, V. R., Nitríni, R., Pasqualucci, C. A., Lin, C. J., Grinberg, L. T., & Suemoto, C. K. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04444-5 · Cited by 1
“One of the key markers of peroxynitrite-induced damage is 3-nitrotyrosine (3-NT), which results from the nitration of tyrosine residues in proteins [9].”
Mancuso, C. (2025) · Antioxidants · doi:10.3390/antiox14101237 · Cited by 1
Coria-Lucero, C. D., Lopez, M., Gomez-Mejiba, S., Ramírez, D. C., Delsouc, M. B., CASAIS, M. A. R. I. L. I. N. A., Alba, R., Leporatti, J., Delgado, S. M., Anzulovich, A. C., et al. (2025) · Brain Research · doi:10.1016/j.brainres.2025.150135
Abdelrahman, K. S., Soltan, O. M., Mansour, H. E. A., Nofal, A. E., Eissa, E. A., Salem, H. R., Mahfouz, M. M., El‐Adawy, S. A., Ewies, G. S. A., Hamdi, A., et al. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118738
Dixit, S., Viswanatha, G. L., & Nayak, Y. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02216-3
“Oxidative stress is a central driver of neuronal dysfunction and cognitive decline in neurodegenerative diseases, and its attenuation is widely regarded as a key indicator of neuroprotective efficacy (Butterfield and Boyd-Kimball 2020).”
Mishra, T., Sharma, S., Joshi, S., Prajapati, S. K., & Tejaswi (2025) · Neurophysiology · doi:10.1007/s11062-026-10002-8
Nanocarriers unveiling ferroptosis as a potential therapeutic target
Sithole, M. N., & Choonara, Y. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33623-2.00017-9
Gallmetzer, E., Mak, E., Kara, F., Zeydan, B., Kapoor, E., SHUFELT, C. L., Rocca, W. A., & Kantarci, K. (2026) · Frontiers in Dementia · doi:10.3389/frdem.2026.1912295
Thakur, A., Sharma, R. R., Kumari, S., Prakash, D., & Devi, A. S. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02371-7
“…positron emission tomography (PET) imaging, have consistently shown decreased mitochondrial enzyme activity, impaired oxidative phosphorylation, and decreased mitochondrial complex I function, which are correlated with cognitive decline (Butterfield and Boyd-Kimball 2020; McGill Percy et al. 2025).”
Metadata
- Authors
- Butterfield, D. A., & Boyd-Kimball, D.
- Affiliations
- University of Kentucky (US)
- Department of Chemistry and Biochemistry, University of Mount Union, Alliance, OH 44601, USA
- Corresponding author
- Butterfield, D. Allan
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2020-09-02
- Volume
- 9
- Issue
- 9
- Pages
- 818
- ISSN
- 2076-3921 (ISSN-L)
- PMC
- PMC7554713
- OpenAlex
- W3082151022
- Cited by
- 85
- References
- 192
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 11 · 2023: 15 · 2022: 13 · 2021: 18
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Antioxidants (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UKnowledge (University of Kentucky) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (AG060056)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amnestic mild cognitive impairment, mitochondrial oxidative stress, nitrosative stress, mitochondria, redox proteomics, free radicals, oxidative modification, biomarkers, neuroimaging, therapeutic target
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.